Medline opens at $35, IPO priced at $29 per share

Medline (MDLN) priced its upsized initial public offering of 216.03M shares of its Class A common stock, at a public offering price of $29.00 per share. Medline identifies itself as “the largest provider of medical-surgical products and supply chain solutions serving all points of care,” noting that the company employs more than 43,000 people worldwide and operates in more than 100 countries. The deal size was raised to 216.03M shares from 179M shares, and the deal priced near the upper end of the $26.00-$30.00 range. Goldman Sachs, Morgan Stanley, BofA, JPMorgan, Barclays, Citi, Deutsche Bank, Jefferies and UBS acted as joint book running managers for the offering.